Cargando…

Prices, Costs, and Affordability of New Medicines for Hepatitis C in 30 Countries: An Economic Analysis

INTRODUCTION: New hepatitis C virus (HCV) medicines have markedly improved treatment efficacy and regimen tolerability. However, their high prices have limited access, prompting wide debate about fair and affordable prices. This study systematically compared the price and affordability of sofosbuvir...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iyengar, Swathi, Tay-Teo, Kiu, Vogler, Sabine, Beyer, Peter, Wiktor, Stefan, de Joncheere, Kees, Hill, Suzanne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4886962/ https://www.ncbi.nlm.nih.gov/pubmed/27243629 http://dx.doi.org/10.1371/journal.pmed.1002032

Ejemplares similares

Impact of External Price Referencing on Medicine Prices – A Price Comparison Among 14 European Countries
por: Leopold, Christine, et al.
Publicado: (2012)

The Pharmaceutical Pricing and Reimbursement Information (PPRI) network – a decade of exchange of information and policy research?
por: Vogler, Sabine, et al.
Publicado: (2015)

Pharmaceutical policies in European countries in response to the global financial crisis
por: Vogler, Sabine, et al.
Publicado: (2011)

Comparison of Prices and Affordability of Cancer Medicines in 16 Countries in Europe and Latin America
por: Moye-Holz, Daniela, et al.
Publicado: (2021)

Can Price Transparency Contribute to More Affordable Patient Access to Medicines?
por: Vogler, Sabine, et al.
Publicado: (2017)

Effect of the economic recession on pharmaceutical policy and medicine sales in eight European countries
por: Leopold, Christine, et al.
Publicado: (2014)

Cost and affordability of nutritious diets at retail prices: Evidence from 177 countries
por: Bai, Yan, et al.
Publicado: (2021)

Comparison of Sales Income and Research and Development Costs for FDA-Approved Cancer Drugs Sold by Originator Drug Companies
por: Tay-Teo, Kiu, et al.
Publicado: (2019)

Affordable Prices Without Threatening the Oncological R&D Pipeline—An Economic Experiment on Transparency in Price Negotiations
por: Franzen, Nora, et al.
Publicado: (2022)

Prices of oncology medicines in European countries, Australia and New Zealand
por: Vogler, Sabine, et al.
Publicado: (2015)

Price, availability and affordability of medicines
por: Mhlanga, Brenda S., et al.
Publicado: (2014)

Insulin prices, availability and affordability in 13 low-income and middle-income countries
por: Ewen, Margaret, et al.
Publicado: (2019)

Cost–effectiveness thresholds: pros and cons
por: Bertram, Melanie Y, et al.
Publicado: (2016)

Open access: What price affordability?
por: Poynder, Richard
Publicado: (2014)

An international analysis of the price and affordability of beer
por: Blecher, Evan, et al.
Publicado: (2018)

Prices, availability and affordability of medicines in Rwanda
por: Bizimana, Thomas, et al.
Publicado: (2020)

Impact of discounts on medicine prices
por: Schneider, Peter, et al.
Publicado: (2015)

Evolution of Average European Medicine Prices: Implications for the Methodology of External Price Referencing
por: Vogler, Sabine, et al.
Publicado: (2019)

Impact of Generic Price Linkage System and Reference Price System on prices of pharmaceuticals – comparison of Austria and Finland
por: Martikainen, Jaana E, et al.
Publicado: (2015)

Impact of changes in the methodology of external price referencing on medicine prices: discrete-event simulation
por: Vogler, Sabine, et al.
Publicado: (2020)

Medicine prices, availability and affordability in Sri Lanka
por: Senarathna, S.M.D.K. Ganga, et al.
Publicado: (2011)

Availability, prices and affordability of essential medicines in Haiti
por: Chahal, Harinder Singh, et al.
Publicado: (2013)

The Availability, Pricing, and Affordability of Essential Diabetes Medicines in 17 Low-, Middle-, and High-Income Countries
por: Babar, Zaheer-Ud-Din, et al.
Publicado: (2019)

Price of a hepatitis C cure: Cost of production and current prices for direct-acting antivirals in 50 countries
por: Barber, Melissa J., et al.
Publicado: (2020)

Measuring the Affordability of Nutritious Diets in Africa: Price Indexes for Diet Diversity and the Cost of Nutrient Adequacy
por: Masters, William A., et al.
Publicado: (2018)

Assessing, Pricing and Funding Point-of-Care Diagnostic Tests for Community-Acquired Acute Respiratory Tract Infections–Overview of Policies Applied in 17 European Countries
por: Vogler, Sabine, et al.
Publicado: (2022)

The Nutrient Rich Food Price Index: a nutrition-relevant adaptation of the Laspeyres price index to track the cost of affordable nutrient density
por: Mendoza-Velázquez, Alfonso, et al.
Publicado: (2023)

Change in cost and affordability of a typical and nutritionally adequate diet among socio-economic groups in rural Nepal after the 2008 food price crisis
por: Akhter, Nasima, et al.
Publicado: (2018)

Availability, prices, and affordability of selected essential cancer medicines in a middle-income country – the case of Mexico
por: Moye-Holz, Daniela, et al.
Publicado: (2020)

Evaluating Drug Prices, Availability, Affordability, and Price Components: Implications for Access to Drugs in Malaysia
por: Babar, Zaheer Ud Din, et al.
Publicado: (2007)

Factors Impacting Pharmaceutical Prices and Affordability: Narrative Review
por: Lee, Kah Seng, et al.
Publicado: (2020)

Is pricing of dolutegravir equitable? A comparative analysis of price and country income level in 52 countries
por: Sim, Joel, et al.
Publicado: (2018)

Availability, price and affordability of cardiovascular medicines: A comparison across 36 countries using WHO/HAI data
por: van Mourik, Maaike SM, et al.
Publicado: (2010)

Access to Cardiovascular Disease and Hypertension Medicines in Developing Countries: An Analysis of Essential Medicine Lists, Price, Availability, and Affordability
por: Husain, Muhammad Jami, et al.
Publicado: (2020)

Cost, affordability and cost-effectiveness of strategies to control tuberculosis in countries with high HIV prevalence
por: Currie, Christine SM, et al.
Publicado: (2005)

Affordability of essential medicine prices in Malaysia’s private health sector
por: Ahmad, Nur Sufiza, et al.
Publicado: (2018)

The availability, price and affordability of essential antibacterials in Hubei province, China
por: Wu, Guangjie, et al.
Publicado: (2018)

Availability, prices and affordability of essential medicines in Zhejiang Province, China
por: Dong, Zuojun, et al.
Publicado: (2020)

Retail pharmacy prescription medicines’ availability, prices and affordability in Eswatini
por: Shambira, Garikai, et al.
Publicado: (2021)

Availability, Price and Affordability of Psychotropic Medicines in Addis Ababa, Ethiopia
por: Habte, Fikreselam, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_l4o12lobt1qfcf1nqq8plrtdjg